first trimester medical abortion: adherence and staff effort

Slides:



Advertisements
Similar presentations
Disclosure I, Peter T. Katzmarzyk, PhD, FACSM, have no relationships with commercial interests to disclose. A commercial interest is any entity producing,
Advertisements

Living with HIV Know Your Rights Privacy and health records The information contained in this publication is information about the law, but it is not legal.
Expanding Medical Education in British Columbia within a Socially Responsible Framework Oscar Casiro, MD, FRCPC Head, Division of Medical Sciences, UVic.
Impact of an EHR Smart Phrase and Resident Education on Adherence to ADA Standards of Medical Care in Diabetes Javier Guevara Jr. MD, Julia Gold MD, Corina.
1 Preparing your office for a resident University of BC Faculty of Medicine Department of Family Practice Post Graduate Program Written by John Edworthy,
When is a backup aspiration needed? hCG and ultrasound for verification of successful expulsion Christian Fiala Gynmed Ambulatorium Vienna, Austria Karolinska.
Integrating medical abortion into safe abortion services in South Africa Jennifer Moodley Margaret Hoffman.
5 DECEMBER 2012 PRESENTER: AS SESING MCWH MANAGER(FSDOH)
Front Line Pharmacist Survey Each director of pharmacy who received an invitation to participate in the 2013/14 survey was asked to forward an to.
Implementing a Rapid HIV Testing Guideline for L&D NNEPQIN April 30, 2007.
H I P A A T R A I N I N G Self Directed Module 7 Research Disclosures For Data Custodians START Click to begin…
 The use of telecommunications technology to provide, enhance, or expedite health care services.  Accessing off-site databases, linking clinics or physicians'
In-Reach Hospital Program In-Reach Hospital Program Coordinating Multiple Service Providers Rare Presentation Partnership between: South Central Human.
Joseph A. Banken, M.A., Ph.D., HSPP Associate Professor Director of Research, Antenatal & Neonatal Guidelines Education and Learning System (ANGELS) University.
The Medical Record, Documentation, and Filing
Levels of Review of Research and Quality Improvement Walter Kraft, MD Associate Director, Office of Human Subjects Protection Department of Pharmacology.
clara bell duvall education fund Medical Abortion with Methotrexate and Misoprostol David Blair Toub, M.D. Department of Obstetrics and Gynecology Pennsylvania.
Abortion research developments Dan Grossman, MD Ibis Reproductive Health June 26, 2008.
HIPAA and RESEARCH 5 th Thursday May 31, Page 2.
Algorithms for Medication Abortion: Making it Safe and Simple Linda Prine MD Dan Napolitano MD Erin Hendricks MD Beth Israel Residency in Urban Family.
The PRECIS-2 tool: Matching Intent with Methods David Hahn, MD, MS, WREN Director Department of Family Medicine & Community Health University.
Pharmacists’ role in a family medicine clinic: a focus on patients with diabetes Benjamin Chavez, PharmD, BCPP, BCACP Associate Professor Pacific University.
Certificates of Confidentiality:
Care Transitions for Medication Safety in the Community
Shubhangi Arora1; Eden Haverfield2; Gabriele Richard2; Susanne B
“ A Statement on Abortion by One Hundred Professors of Obstetrics
Gynaecological Emergencies:
Risk of stroke at 3 months6 Expected Strokes at 3 months
Dr Caitriona Henchion Medical Director
Integrated Behavioral Health: Ethical Considerations
Facilitation Tool: Goal to Action template
Lawyer Paralegals and related occupations perform research and document preparation duties in law firms, legal departments in the private and public.
Patient Focused Drug Development An FDA Perspective
“Its Different Now”: The Changing Landscape of HIV testing
Office of Health Systems Collaboration
MAINTAINING THE INVESTIGATOR’S SITE FILE
Ethics Education in Neurosurgery- A Survey of North American Program Directors N Rajmohamed, A Cheong BSc, J Riva-Cambrin MD, AV Kulkarni MD, PJ McDonald.
INTERNSHIP CORE SITE PROFILE SITE: Island Health
The HIPAA Privacy Rule: Implications for Medical Research
Ellen R Wiebe MD 1,2, Cheryl Couldwell 2
Charlotte Crist, BS, RN-BC, CCM, CPHQ
The Problem of Multiple Hats: Providing efficient and safe team-based care with providers who are not always in the clinic. Frank Babb, MD David RM Trotter,
Transgender and Gender Nonconforming Patients’ Ob/Gyn Care: “Gender-equal” health services templates Gloria Bachmann MD1, Brianna Mussman2, Anthony Tobia.
What Are the Barriers to Opt-out HIV testing?
APHA 135th Annual Meeting and Expo November 3-7, 2007 Washington, DC
Ambulatory Neonatal Circumcision Clinic in a Family Medicine Residency
Facilitator: pawin puapornpong
Leigh E. Tenkku, PhD, MPH Department of Family and Community Medicine
Use Your Wisely Campaign
Good Clinical Practice
Addiction and Primary Care Access
PeArLS (Personally Arranged Learning Session)
Medical Assistance in Dying on Vancouver Island -the first year
UOG Journal Club: January 2018
Chapter 12 Health Facility Settings
MHEALTH to Improve Health: Effectiveness of a weekly text messaging intervention to improve ART adherence and HIV Viral Load: WelTel OAKTREE. M.C.M. Murray1,2,3,
Patterns of asthma medications prescriptions among adult patients in the chest and accident and emergency units of a tertiary health care facility in Uganda.
The CARE Initiative New Positives Known Positives
Cluster Randomized Trials
Improved Latent Tuberculosis Therapy Completion Rates in Refugee Patients Through Use of a Clinical Pharmacist Kimberly L. Carter, Pharm.D., BCACP Assistant.
Sarah Siddiqui, MD, MPH University of Texas Medical Branch
Therapeutic Abortions in Northern BC
Dr. Glen E. Randall Dr. Michelle Howard McMaster University
National Hospital for Neurology and Neurosurgery,
MAINTAINING THE INVESTIGATOR’S STUDY FILE
CLEVE ZIEGLER, M.D. FRCS JEWISH GENERAL HOSPITAL
Updates to the PhRMA Code on Interactions with Healthcare Professionals National Pharma Audioconference August 5, 2008.
Pattye Anderson, MSN, FNP bc USC C/O 1994 UCLA c/o 2004
In 2006, 80% of Canadians lived in urban centres
Midwifery Symposium, Whitehorse, Yukon
Presentation transcript:

first trimester medical abortion: adherence and staff effort Email follow-up after first trimester medical abortion: adherence and staff effort Tika Okuda1 & Kirsten Duckitt2 September 15, 2017 1University of British Columbia, Island Medical Program, BC 2 Department of Obstetrics and Gynecology, Clinical Associate Professor UBC, Campbell River, BC

Affiliations University of British Columbia Faculty of Medicine University of Victoria, Island Medical Program Island Health Authority

Disclosure I have no disclosures

Understanding the Problem Map notes locations of medical first trimester abortion providers Vancouver Island is 31,285km2 and 460km long South Isl1: (61-64) Pop: 383,360 Central Isl1: (65-70) Pop: 270,418 North Isl1: (71,72,84,85) Pop: 122,233 Distance to providers can be great due to the large geographical area and limited motorways. Eg. driving time from Port Hardy (northern end) to Campbell River is 2.5 hours. In addition multiple small Island communities are served with infrequent sailings. This study is based in Campbell River 2:http://www.viha.ca/about_viha 1; Statistics Canada. 2017. Campbell River [Population centre], British Columbia and British Columbia [Province] (table). Census Profile. 2016 Census. Statistics Canada Catalogue no. 98-316-X2016001. Ottawa. Released August 2, 2017. http://www12.statcan.gc.ca/census-recensement/2016/dp-pd/prof/index.cfm?Lang=E (accessed August 23, 2017). 1) Statistics Canada 2016 Census Population 2) Image: http://www.viha.ca/about_viha

Methods Retrospective chart review of medical abortions following SOGC 2006 guidelines1 January 2012- December 2016 Protocol used Methotrexate and Misoprostol and successful treatment was noted by a serial drop in quantitative B-hCG of > 80% Every patient was considered to require one email from the medical provider Lost to follow-up: inconclusive B-hCG and no response to email or telephone communication Extra email correspondence: any patient requiring more than one email Completely lost to follow-up: unknown status post chart review (May 2017) Serial labs= 1 pre treatment B-hCG and 2 subsequent tests 7 days after each other. 1)http://old.sogc.org/wp-content/uploads/2013/01/gui184E0611.pdf

Results 469 requested medical abortion services 462 prescriptions given 7 declined prescriptions 278 B-hCG drop in initial set of 2 labs 179- more than one email 5 presented to ER for RPOC 5 D&C 116 < 80% B-hCG drop or less than 2 serum levels 16 no bleeding, no labs drawn 47 required extra prescriptions 15 emailed in with signs & symptoms of success 57 lost to follow up 44 D&C 16 D&C 47 Successful medical abortion 33 completely lost to follow up 24 found through chart review RPOC= retained products of conception D&C= dilatation and curettage Yellow= required extra email communication Red= lost to follow up 462 people requested and received counselling for the procedure. 18 successful medical abortion 6 D&C

Results Adherence rates 12.3% (57/462) lost to f/u Staff effort 38.7% (179/462) required extra communication

Results Staff effort 8.9% (16/179) emailed-in no bleeding → D&C 26.3% (47/179) required an extra prescription 24.6% (44/179) needed to return for a D&C Compliance with serial B-hCG levels 16.3% 72/(462-5-16) had less than 2 lab tests 3.4% 15/(462-5-16) emailed in signs of success See the breakdown of emails sent by the medical provider.

This is a retrospective chart review, which is limited to a patient population on Vancouver Island. The noted trends could be biased due to location or patient population of the provider. Extra email correspondence was set based on each patient requiring one email from the care provider. However, this does not reflect the number of extra emails or time required for each response. Limitations

Discussion: Adherence to Follow-up and B-hCG Patient compliance Only 16.3% completed less than 2 B- hCG values. Considering limited laboratory locations, barriers to travel like distance, and poor public transportation this is a small number of non compliant patients Email adherence rates are acceptable A Canadian Study from 2015 notes complete lost to f/u rates for telephone and office visits at 4.8% and 5.6% respectively1 This email f/u study had a complete lost to f/u rate of 7.1%. Of note 3.4% of the 16.3% of laboratory non-adherence emailed in with perceived signs of successful medical abortion; including, return of menstruation. Emailing the care provider presumed signs and symptoms of a successful medical abortion is not an encouraged form of follow-up but allowed the patient to communicate with their medical provider and overcome some of the noted barriers to this patient population. Comparing office and telephone follow-up after medical abortion. Chen MJ, et al. Contraception. 2016.Authors Chen MJ1, Rounds KM2, Creinin MD2, Cansino C2, Hou MY2. https://www.ncbi.nlm.nih.gov/m/pubmed/27101901/?i=22&from=follow%20up%20rates%20after%20abortion# 1)Chen MJ. et al., 2015. Comparing office and telephone follow-up after medical abortion: https://www.ncbi.nlm.nih.gov/m/pubmed/27101901/?i=22&from=follow%20up%20rates%20after%20abortion

Discussion: Staff Effort Email is a viable tool A Canadian Study on medical abortion f/u from 2015 notes 43.9% required more than one telephone call1. The noted 38.7% of patients who required extra communication is expected. Templates can streamline f/u MIFEGYMISO might decrease % requiring extra communication Clinical Pearl The legal risks of email communications are clearly outlined by the Canadian Medical Protective Association and a consent form is available2. Each physician should look at the email communication statement from their governing College of Physicians and Surgeons Comparing office and telephone follow-up after medical abortion. Chen MJ, et al. Contraception. 2016.Authors Chen MJ1, Rounds KM2, Creinin MD2, Cansino C2, Hou MY2. https://www.ncbi.nlm.nih.gov/m/pubmed/27101901/?i=22&from=follow%20up%20rates%20after%20abortion# 1)Chen MJ, 2015. Comparing office and telephone follow-up after medical abortion: https://www.ncbi.nlm.nih.gov/m/pubmed/27101901/?i=22&from=follow%20up%20rates%20after%20abortion 2)https://www.cmpa-acpm.ca/static-assets/pdf/advice-and-publications/risk-management-toolbox/com_16_consent_to_use_electronic_communication_form-e.pdf

In 2016 medical abortions made up 3 In 2016 medical abortions made up 3.8% of Canadian first trimester abortions1. With the recent approval of MIFEGYMISO in Canada this number will hopeful increase.. Future studies should include and compare rural and urban populations Pragmatic, preference trial to compare lost to f/u rates and staff effort with; office, telephone, telemedicine and email follow-up Qualitative study on patients’ perceptions of email communication and privacy Investigate barriers to physician uptake of emaeil correspondnce Future Directions Our site about 40% are medidal of campbell river has MIFEGYMISO (mifepristone and misoprostol tablets) which has less teratogenic effects 1) Guilbert, E., etc., 2016. First-trimester medical abortion practices in Canada https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4830676/